Yu-chien Ho
Number 201, Shih Pai Road
Beitou, TPQ 11217, Taiwan
Beitou, TPQ 11217, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Risk factors for in vivo emergence of ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae and the associated resistance mechanisms: a case-control study.
Journal: Microbiology spectrum
Published: May 04, 2026
Klebsiella Pneumoniae Liver Abscess as the Herald of Underlying Colorectal Neoplasm.
Journal: Open forum infectious diseases
Published: November 30, 2025
Clinical outcomes of immunocompromised patients administered tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 27, 2025
Clinical outcomes of immunocompromised patients administered tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: Real-world experience in Taiwan.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 27, 2025
Carbapenems versus non-carbapenems as definitive treatment for hypervirulent Klebsiella pneumoniae bacteremia in Taiwan.
Journal: Antimicrobial agents and chemotherapy
Published: November 18, 2025
Prognostic factors for mortality and respiratory failure in hospitalized patients with COVID-19 after three-dose vaccination: a retrospective cohort study during the Omicron period.
Journal: BMC infectious diseases
Published: July 24, 2025
Comparison of Effectiveness between Ceftazidime/Avibactam and Other Active Therapies for Oxacillinase-48-Producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Taiwan.
Journal: Infectious diseases and therapy
Published: July 07, 2025
Clinical and Microbiological characteristics of patients with ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains.
Journal: Annals of clinical microbiology and antimicrobials
Published: February 11, 2025
Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia.
Journal: Journal of infection and public health
Published: February 07, 2025
Clinical Characteristics of Patients Who Acquired Gram-Negative Bacteria During Ceftazidime-Avibactam Therapy.
Journal: Infectious diseases and therapy
Published: November 24, 2024
Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan.
Journal: Journal of infection and public health
Published: July 24, 2024
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan.
Journal: International journal of antimicrobial agents
Published: April 03, 2024
Last Updated: 09/26/2026